{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T01:10:27Z","timestamp":1777857027001,"version":"3.51.4"},"reference-count":45,"publisher":"SAGE Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JND"],"published-print":{"date-parts":[[2022,3,1]]},"abstract":"<jats:p>Background: Late onset Pompe disease (LOPD) is rare and generally manifests predominantly as progressive limb girdle muscle weakness. It is linked to the pathogenic mutations in GAA gene, which leads to glycogen accumulation in various tissues. Materials and methods: We describe the unusual clinical, biochemical, histopathological and genetic characteristics of 5 cases of LOPD. Results: The first case had progressive anterior horn cell like disease (AHCD) that evolved later to classical limb girdle syndrome and respiratory failure, the second patient had rigid spine syndrome with gastrointestinal manifestations, the third had limb girdle weakness superimposed with episodic prolonged worsening and respiratory failure, the fourth had large fibre sensory neuropathy without primary muscle involvement and the fifth presented with classical limb girdle muscle weakness. Two homozygous missense mutations c.1461C\u200a&gt;\u200aA (p.Phe487Leu) and c.1082C\u200a&gt;\u200aT (p.Pro361Leu) in the GAA gene were identified in case 1 and 2 respectively. Case 3 was compound heterozygous with inframe c.1935_1940del (p.Val646_Cys647del) and an intronic splice effecting variant c.-32-13T\u200a&gt;\u200aG. Compound heterozygous missense variants c.971C\u200a&gt;\u200aT (p.Pro324Leu) and c.794G\u200a&gt;\u200aA (p.Ser265Asn) were identified in case 4. Case 5 had a frameshift insertion c.1396dupG (p.Val466GlyfsTer40) and a synonymous splice affecting variant c.546G\u200a&gt;\u200aT(p.Thr182=). Conclusion: We are describing for the first time from India on LOPD with unusual phenotypes identified. A high degree of clinical suspicion and diagnosing rare phenotypes of Pompe disease is imperative to consider early initiation of Enzyme Replacement Therapy (ERT).<\/jats:p>","DOI":"10.3233\/jnd-210728","type":"journal-article","created":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T17:13:24Z","timestamp":1638292404000},"page":"261-273","source":"Crossref","is-referenced-by-count":3,"title":["Late Onset Pompe Disease with Novel Mutations and Atypical Phenotypes"],"prefix":"10.1177","volume":"9","author":[{"given":"Tanushree","family":"Chawla","sequence":"first","affiliation":[{"name":"Department of Neurology, National Institute of Mental Health and Neurosciences, Bangalore, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veeramani","family":"Preethish-Kumar","sequence":"additional","affiliation":[{"name":"Department of Neurology, National Institute of Mental Health and Neurosciences, Bangalore, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiran","family":"Polavarapu","sequence":"additional","affiliation":[{"name":"Department of Neurology, National Institute of Mental Health and Neurosciences, Bangalore, India"},{"name":"Children\u2019s Hospital of Eastern Ontario Research Institute; Division of Neurology, Department of Medicine, The Ottawa Hospital; Brain and Mind Research Institute, University of Ottawa, Ottawa, ON, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seena","family":"Vengalil","sequence":"additional","affiliation":[{"name":"Department of Neurology, National Institute of Mental Health and Neurosciences, Bangalore, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mainak","family":"Bardhan","sequence":"additional","affiliation":[{"name":"Department of Neurology, National Institute of Mental Health and Neurosciences, Bangalore, India"},{"name":"Division of Bacteriology, ICMR-National Institute of Cholera and Enteric Diseases, Kolkata, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"RatnaDua","family":"Puri","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics and Genomics, Sir Ganga Ram Hospital, New Delhi, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jyotsna","family":"Verma","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics and Genomics, Sir Ganga Ram Hospital, New Delhi, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita","family":"Christopher","sequence":"additional","affiliation":[{"name":"Department of Neurochemistry, National Institute of Mental Health and Neurosciences, Bangalore, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manjunath","family":"Supriya","sequence":"additional","affiliation":[{"name":"Department of Neurochemistry, National Institute of Mental Health and Neurosciences, Bangalore, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saraswati","family":"Nashi","sequence":"additional","affiliation":[{"name":"Department of Neurology, National Institute of Mental Health and Neurosciences, Bangalore, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chandrajit","family":"Prasad","sequence":"additional","affiliation":[{"name":"Department of Neuro Imaging and Interventional Radiology, National Institute of Mental Health and Neurosciences, Bangalore, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bevinahalli","family":"Nadeesh","sequence":"additional","affiliation":[{"name":"Department of Neuropathology, National Institute of Mental Health and Neurosciences, Bangalore, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atchayaram","family":"Nalini","sequence":"additional","affiliation":[{"name":"Department of Neurology, National Institute of Mental Health and Neurosciences, Bangalore, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","reference":[{"key":"10.3233\/JND-210728_ref1","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.jpeds.2013.01.031","article-title":"Identification of infants at risk for developing Fabry, Pompe, or mucopolysaccharidosis-I from newborn blood spots by tandem mass spectrometry","volume":"163","author":"Scott","year":"2013","journal-title":"J. Pediatr"},{"key":"10.3233\/JND-210728_ref2","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jpeds.2014.09.023","article-title":"Lysosomal storage disorder screening implementation: findings from the first six months of full population pilot testing in Missouri","volume":"166","author":"Hopkins","year":"2015","journal-title":"J. Pediatr"},{"key":"10.3233\/JND-210728_ref3","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.resp.2013.06.007","article-title":"The respiratory neuromuscular system in Pompe disease","volume":"189","author":"Fuller","year":"2013","journal-title":"Respir Physiol. Neurobiol"},{"key":"10.3233\/JND-210728_ref4","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1212\/WNL.0b013e31818da91e","article-title":"Diagnosis of glycogenosis type II","volume":"71","author":"Bembi","year":"2008","journal-title":"Neurology"},{"key":"10.3233\/JND-210728_ref5","first-page":"267","article-title":"Pompe disease diagnosis and management guideline","volume":"8","author":"Kishnani","year":"2006","journal-title":"Genet. Med. Off. J. Am. Coll. Med. Genet"},{"key":"10.3233\/JND-210728_ref6","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/ajmg.c.31319","article-title":"Predicting Cross Reactive Immunological Material (CRIM) Status in Pompe Disease Using GAA Mutations: Lessons Learned from 10 Years of Clinical Laboratory Testing Experience","volume":"160","author":"Bali","year":"2012","journal-title":"Am. J. Med. Genet. C Semin. Med. Genet"},{"key":"10.3233\/JND-210728_ref7","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/ejhg.2010.188","article-title":"Splicing mutations in glycogen-storage disease type II: evaluation of the full spectrum of mutations and their relation to patients\u2019 phenotypes","volume":"19","author":"Zampieri","year":"2011","journal-title":"Eur. J. Hum. Genet"},{"key":"10.3233\/JND-210728_ref8","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1212\/01.wnl.0000252798.25690.76","article-title":"Broad spectrum of Pompe disease in patients with the same c-32-13T-\u200a>\u200aG haplotype","volume":"68","author":"Kroos","year":"2007","journal-title":". Neurology"},{"key":"10.3233\/JND-210728_ref9","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.cccn.2004.04.009","article-title":"Glycogen storage disease type II: enzymatic screening in dried blood spots on filter paper","volume":"347","author":"Chamoles","year":"2004","journal-title":"Clin. Chim. Acta Int. J. Clin. Chem"},{"key":"10.3233\/JND-210728_ref10","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.nmd.2019.10.010","article-title":"The 2020 version of the gene table of neuromuscular disorders (nuclear genome)","volume":"29","author":"Benarroch","year":"2019","journal-title":"Neuromuscul. Disord"},{"key":"10.3233\/JND-210728_ref11","first-page":"405","article-title":"Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med. Off. J. Am. Coll. Med. Genet"},{"key":"10.3233\/JND-210728_ref12","first-page":"233","article-title":"Autophagic glycogenosis of late onset with mitochondrial abnormalities: light and electron microscopic observations","volume":"43","author":"Engel","year":"1968","journal-title":"Mayo Clin Proc"},{"key":"10.3233\/JND-210728_ref14","doi-asserted-by":"crossref","first-page":"E13","DOI":"10.1002\/humu.20745","article-title":"GAA Database Consortium, Update of the Pompe disease mutation database with 107 sequence variants and a format for severity rating","volume":"29","author":"Kroos","year":"2008","journal-title":"Hum. Mutat"},{"key":"10.3233\/JND-210728_ref15","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/jhg.2009.66","article-title":"Silent exonic mutation in the acid-alpha-glycosidase gene that causes glycogen storage disease type II by affecting mRNA splicing","volume":"54","author":"Maimaiti","year":"2009","journal-title":"J. Hum. Genet"},{"key":"10.3233\/JND-210728_ref16","first-page":"15","article-title":"Clinical and GAA gene mutation analysis in mainland Chinese patients with late-onset Pompe disease: identifying c.2238G\u200a>\u200aC as the most common mutation","author":"Liu","year":"2014","journal-title":"BMC Med. Genet"},{"key":"10.3233\/JND-210728_ref17","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1007\/s00415-015-7664-0","article-title":"Clinical and molecular aspects of 30 patients with late-onset Pompe disease (LOPD): unusual features and response to treatment","volume":"262","author":"Montagnese","year":"2015","journal-title":"J. Neurol"},{"key":"10.3233\/JND-210728_ref18","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.1365-2990.2007.00839.x","article-title":"Adult-onset glycogen storage disease type 2: clinico-pathological phenotype revisited","volume":"33","author":"Schoser","year":"2007","journal-title":"Neuropathol. Appl. Neurobiol"},{"key":"10.3233\/JND-210728_ref19","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/00005072-196501000-00008","article-title":"POMPE\u2019S DISEASE (DIFFUSE GLYCOGENOSIS) WITH NEURONAL STORAGE","volume":"24","author":"Mancall","year":"1965","journal-title":"J. Neuropathol. ExNeurol"},{"key":"10.3233\/JND-210728_ref21","doi-asserted-by":"crossref","first-page":"9419","DOI":"10.1073\/pnas.0902534106","article-title":"Neural deficits contribute to respiratory insufficiency in Pompe disease","volume":"106","author":"DeRuisseau","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.3233\/JND-210728_ref22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ymgme.2011.02.004","article-title":"Pompe disease: design, methodology, and early findings from the Pompe Registry","volume":"103","author":"Byrne","year":"2011","journal-title":"Mol. Genet. Metab"},{"key":"10.3233\/JND-210728_ref23","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.resp.2016.02.007","article-title":"Neuropathology in respiratory-related motoneurons in young Pompe (Gaa(-\/-)) mice","volume":"227","author":"Turner","year":"2016","journal-title":"Respir. Physiol. Neurobiol"},{"key":"10.3233\/JND-210728_ref24","unstructured":"Hirschhorn R , Reuser AJJ . Glycogen Storage Disease 135 Type II: Acid a-Glucosidase (Acid Maltase) Deficiency. 2001:32."},{"key":"10.3233\/JND-210728_ref25","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1017\/cjn.2016.447","article-title":"Fasciculations in Late-Onset Pompe Disease: A Sign of Motor Neuron Involvement?","volume":"44","author":"Monforte","year":"2017","journal-title":"Can. J. Neurol. Sci"},{"key":"10.3233\/JND-210728_ref27","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1002\/mus.21076","article-title":"Intracerebral hemorrhage in a patient with glycogenosis type II (Pompe disease): is there a pathophysiological relationship?","volume":"38","author":"Brettschneider","year":"2008","journal-title":"Muscle Nerve"},{"key":"10.3233\/JND-210728_ref28","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1007\/s00415-010-5618-0","article-title":"Abnormalities of cerebral arteries are frequent in patients with late-onset Pompe disease","volume":"257","author":"Sacconi","year":"2010","journal-title":"J. Neurol"},{"key":"10.3233\/JND-210728_ref29","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.nmd.2009.11.006","article-title":"Rigid spine syndrome revealing late-onset Pompe disease","volume":"20","author":"Lafor\u00eat","year":"2010","journal-title":"Neuromuscul. Disord. NMD"},{"key":"10.3233\/JND-210728_ref30","first-page":"26","article-title":"Rigid spine syndrome in Late-Onset Pompe Disease: a syndrome of paravertebral muscle hyperactivity","author":"Ng","year":"2021","journal-title":"Neurol. Asia"},{"key":"10.3233\/JND-210728_ref32","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s10545-015-9825-9","article-title":"Skeletal muscle quantitative nuclear magnetic resonance imaging follow-up of adult Pompe patients","volume":"38","author":"Carlier","year":"2015","journal-title":"J. Inherit. Metab. Dis"},{"key":"10.3233\/JND-210728_ref33","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/mus.880010105","article-title":"Adult-onset acid maltase deficiency: a postmortem study","volume":"1","author":"DiMauro","year":"1978","journal-title":"Muscle Nerve"},{"key":"10.3233\/JND-210728_ref34","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.ymgme.2012.05.007","article-title":"Autopsy findings in late-onset Pompe disease: a case report and systematic review of the literature","volume":"106","author":"Hobson-Webb","year":"2012","journal-title":"Mol. Genet. Metab"},{"key":"10.3233\/JND-210728_ref35","doi-asserted-by":"crossref","first-page":"196","DOI":"10.12659\/AJCR.893309","article-title":"Small-fiber neuropathy in pompe disease: first reported cases and prospective screening of a clinic cohort","volume":"16","author":"Hobson-Webb","year":"2015","journal-title":"Am. J. Case Rep"},{"key":"10.3233\/JND-210728_ref36","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.nmd.2019.08.016","article-title":"Late-onset Pompe disease associated with polyneuropathy","volume":"29","author":"Lamartine","year":"2019","journal-title":"Neuromuscul. Disord. NMD"},{"key":"10.3233\/JND-210728_ref37","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.nmd.2016.09.001","article-title":"The frequency of late-onset Pompe disease in pediatric patients with limb-girdle muscle weakness and nonspecific hyperCKemia: A multicenter study","volume":"26","author":"\u00dcnever","year":"2016","journal-title":"Neuromuscul. Disord. NMD"},{"key":"10.3233\/JND-210728_ref38","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1212\/WNL.0000000000002758","article-title":"Prevalence of Pompe disease in 3,076 patients with hyperCKemia and limb-girdle muscular weakness","volume":"87","author":"Lukacs","year":"2016","journal-title":"Neurology"},{"key":"10.3233\/JND-210728_ref39","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/ane.12460","article-title":"Search for Pompe disease among patients with undetermined myopathies","volume":"133","author":"Lindberg","year":"2016","journal-title":"Acta Neurol. Scand"},{"key":"10.3233\/JND-210728_ref40","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1590\/0004-282x20180018","article-title":"Late-onset Pompe disease: what is the prevalence of limb-girdle muscular weakness presentation?","volume":"76","author":"Lorenzoni","year":"2018","journal-title":"Arq. Neuropsiquiatr"},{"key":"10.3233\/JND-210728_ref41","doi-asserted-by":"crossref","unstructured":"P. N, L. Z, V. L, M. Kl, H. E, H. Rs, D. M, A. H, L. M, V. J,. Late-onset Pompe Disease Is Prevalent in Unclassified Limb-Girdle Muscular Dystrophies. Mol. Genet. Metab. 2013;110. https:\/\/doi.org\/10.1016\/j.ymgme.2013.08.005","DOI":"10.1016\/j.ymgme.2013.08.005"},{"key":"10.3233\/JND-210728_ref42","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s10545-014-9751-2","article-title":"Ten years of the international Pompe survey: patient reported outcomes as a reliable tool for studying treated and untreated children and adults with non-classic Pompe disease","volume":"38","author":"van der Meijden","year":"2015","journal-title":"J. Inherit. Metab. Dis"},{"key":"10.3233\/JND-210728_ref43","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1750-1172-7-73","article-title":"Effect of enzyme therapy and prognostic factors in 69 adults with Pompe disease: an open-label single-center study","volume":"7","author":"de Vries","year":"2012","journal-title":"Orphanet J. Rare Dis"},{"key":"10.3233\/JND-210728_ref44","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ymgme.2012.09.015","article-title":"Open-label extension study following the Late-Onset Treatment Study (LOTS) of alglucosidase alfa","volume":"107","author":"van der Ploeg","year":"2012","journal-title":"Mol. Genet. Metab"},{"key":"10.3233\/JND-210728_ref45","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s00415-012-6636-x","article-title":"Enzyme replacement therapy in late-onset Pompe disease: A systematic literature review","volume":"260","author":"Toscano","year":"2013","journal-title":"J. Neurol"},{"key":"10.3233\/JND-210728_ref46","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s00415-016-8219-8","article-title":"Survival and long-term outcomes in late-onset Pompe disease following alglucosidase alfa treatment: a systematic review and meta-analysis","volume":"264","author":"Schoser","year":"2017","journal-title":"J. Neurol"},{"key":"10.3233\/JND-210728_ref47","doi-asserted-by":"crossref","unstructured":"Sarah B , Giovanna B , Emanuela K , Nadi N , Jos\u00e8 V , Alberto P . Clinical efficacy of the enzyme replacement therapy in patients with late-onset Pompe disease: a systematic review and a meta-analysis. J. Neurol. (2021). https:\/\/doi.org\/10.1007\/s00415-021-10526-5","DOI":"10.1007\/s00415-021-10526-5"},{"key":"10.3233\/JND-210728_ref48","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/mus.22329","article-title":"AANEM Consensus Committee on Late-onset Pompe Disease, Consensus treatment recommendations for late-onset Pompe disease","volume":"45","author":"Cupler","year":"2012","journal-title":"Muscle Nerve"},{"key":"10.3233\/JND-210728_ref49","first-page":"31","article-title":"Exercise, nutrition and enzyme replacement therapy are efficacious in adult Pompe patients: report from EPOC Consortium","author":"Angelini","year":"2021","journal-title":"Eur. J. Transl. Myol"}],"container-title":["Journal of Neuromuscular Diseases"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JND-210728","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T23:49:56Z","timestamp":1777506596000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JND-210728"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,1]]},"references-count":45,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.3233\/jnd-210728","relation":{},"ISSN":["2214-3599","2214-3602"],"issn-type":[{"value":"2214-3599","type":"print"},{"value":"2214-3602","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,1]]}}}